Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Papaseit

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Pharmaceuticals (Basel, Switzerland)|January 16, 2021
Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical CannabisFrancesco Paolo Busardò, Ana Pilar Pérez-Acevedo, Roberta Pacifici, et al.
Clinical Pharmacology and Therapeutics|March 1, 2019
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic VariationEulàlia Olesti, Magí Farré, Marcel Lí Carbó, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2024
Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMSMarta Massano, Melani Nuñez-Montero, Esther Papaseit, et al.
Biology|April 3, 2021
Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational UsersNunzia La Maida, Esther Papaseit, Lucia Martínez, et al.
Frontiers in Psychiatry|May 17, 2021
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFrancina Fonseca, William Lenahan, Richard C Dart, et al.
The AAPS Journal|January 9, 2025
Early and Mid-Term Disposition of α-PVP and its unknown Metabolites in Urine and Oral Fluid Through a Multi-Analytical Hyphenated Approach Following a Single Non-Controlled Administration to Healthy VolunteersAnnagiulia Di Trana, Nunzia La Maida, Georgina de la Rosa, et al.
International Journal of Molecular Sciences|December 11, 2022
Methylone and MDMA Pharmacokinetics Following Controlled Administration in HumansLourdes Poyatos, Alfredo Fabrizio Lo Faro, Diletta Berardinelli, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 27, 2026
First enantioselective determination of N-ethylpentedrone and its major phase-1 metabolites using supercritical fluid chromatography coupled with tandem mass spectrometry and its application to human oral fluid and urine samplesSaba Jorbenadze, Aluda Tchelidze, Giorgia Sprega, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Pharmaceuticals (Basel, Switzerland)|January 16, 2021
Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical CannabisFrancesco Paolo Busardò, Ana Pilar Pérez-Acevedo, Roberta Pacifici, et al.
Clinical Pharmacology and Therapeutics|March 1, 2019
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic VariationEulàlia Olesti, Magí Farré, Marcel Lí Carbó, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2024
Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMSMarta Massano, Melani Nuñez-Montero, Esther Papaseit, et al.
Biology|April 3, 2021
Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational UsersNunzia La Maida, Esther Papaseit, Lucia Martínez, et al.
Frontiers in Psychiatry|May 17, 2021
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFrancina Fonseca, William Lenahan, Richard C Dart, et al.
The AAPS Journal|January 9, 2025
Early and Mid-Term Disposition of α-PVP and its unknown Metabolites in Urine and Oral Fluid Through a Multi-Analytical Hyphenated Approach Following a Single Non-Controlled Administration to Healthy VolunteersAnnagiulia Di Trana, Nunzia La Maida, Georgina de la Rosa, et al.
International Journal of Molecular Sciences|December 11, 2022
Methylone and MDMA Pharmacokinetics Following Controlled Administration in HumansLourdes Poyatos, Alfredo Fabrizio Lo Faro, Diletta Berardinelli, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 27, 2026
First enantioselective determination of N-ethylpentedrone and its major phase-1 metabolites using supercritical fluid chromatography coupled with tandem mass spectrometry and its application to human oral fluid and urine samplesSaba Jorbenadze, Aluda Tchelidze, Giorgia Sprega, et al.
Pageof 9